VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

HCW Biologics Inc. (HCWB) Total Return Calculator with Dividends Reinvested

HCW Biologics Inc.

Popular:

The total return for HCW Biologics Inc. (HCWB) stock is -94.75% over the past 12 months. So far it's down 68.71% this year. The 5-year total return is -99.86%, meaning $10,000 invested in HCWB stock 5 years ago would be worth $14 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in HCWB 1 year ago, it would be worth $500 today — you'd have lost $9,500.

With Dividends Reinvested$500-95.00%

Price Only (No DRIP)$500-95.00%

Period2025-05-07 → 2026-05-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in HCWB

1Y$525-$9,475 (-94.8%)-94.8% CAGR

3Y$62-$9,938 (-99.4%)-81.7% CAGR

5Y$14-$9,986 (-99.9%)-73.2% CAGR

10Y$14-$9,986 (-99.9%)-48.2% CAGR

15Y$14-$9,986 (-99.9%)-35.5% CAGR

20Y$14-$9,986 (-99.9%)-28.0% CAGR

30Y$14-$9,986 (-99.9%)-19.7% CAGR

HCW Biologics Inc. did not pay dividends during this period. Total return = price return.

Loading HCWB total return...

As of 2026-05-07

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-68.71%	—	-68.71%	—	$3,129
1Y	-94.75%	-94.75%	-94.75%	—	$525
3Y	-99.38%	-81.66%	-99.38%	—	$62
5Y	-99.86%	-73.17%	-99.86%	—	$14
10Y	-99.86%	-48.20%	-99.86%	—	$14
15Y	-99.86%	-35.50%	-99.86%	—	$14
20Y	-99.86%	-28.03%	-99.86%	—	$14
30Y	-99.86%	-19.69%	-99.86%	—	$14

Risk & Highlights

Best Year-19.21%2022

Worst Year-94.64%2025

Max Drawdown-97.33%2025-05-13 → 2026-04-02

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-51.73%	-51.73%	—	+0.41%	-52.1pp
2025	-94.64%	-94.64%	—	+16.64%	-111.3pp
2024	-62.83%	-62.83%	—	+24.00%	-86.8pp
2023	-37.24%	-37.24%	—	+24.81%	-62.1pp
2022	-19.21%	-19.21%	—	-19.95%	+0.7pp

HCWB underperformed the S&P 500 by 126.08pp over the past year (-94.75% vs +31.32%).

Loading summary...

HCWB Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
HCWBHCW Biologics Inc.	$14M	+22.0%	-68.7%	-94.8%	—	-99.4%	-99.9%	-99.9%
IMVTImmunovant, Inc.	$5.8B	+15.2%	+10.7%	+107.2%	—	+48.4%	+73.9%	+188.1%
ARQTArcutis Biotherapeutics, Inc.	$3.0B	+2.2%	-16.7%	+68.8%	—	+69.5%	-25.9%	+10.9%
KYMRKymera Therapeutics, Inc.	$7.0B	+1.2%	+18.6%	+201.9%	—	+211.0%	+110.5%	+159.4%
RCUSArcus Biosciences, Inc.	$2.6B	+16.9%	+11.6%	+220.2%	—	+31.0%	-13.7%	+52.9%
TGTXTG Therapeutics, Inc.	$6.7B	+24.6%	+43.3%	+20.4%	—	+26.8%	+5.3%	+425.9%
AGIOAgios Pharmaceuticals, Inc.	$1.6B	-22.5%	-0.7%	-4.7%	—	+6.2%	-51.0%	-38.1%
FATEFate Therapeutics, Inc.	$264M	+92.4%	+131.3%	+139.1%	—	-58.0%	-97.0%	+33.9%
NKTRNektar Therapeutics	$1.7B	+13.9%	+96.0%	+783.6%	—	+636.7%	-69.4%	-57.6%
XNCRXencor, Inc.	$954M	+4.6%	-12.8%	+53.8%	—	-52.4%	-67.2%	+14.8%
MGNXMacroGenics, Inc.	$191M	-5.3%	+87.0%	+104.8%	—	-58.4%	-90.6%	-83.4%

Compare:HCWB vs IMVT HCWB vs ARQT HCWB vs KYMR HCWB vs IMVT vs ARQT

About HCWB Dividend Returns

HCW Biologics Inc. (HCWB) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of HCWB over the past year?

HCW Biologics Inc. (HCWB) delivered a return of -94.75% over the past year. Since HCWB does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in HCWB be worth today?

A $10,000 investment in HCW Biologics Inc. one year ago would be worth $525 today, representing a loss of $9,475.

Q3Does HCWB pay dividends?

HCW Biologics Inc. (HCWB) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For HCWB, the total return equals the price-only return.

Q4Did HCWB beat the S&P 500?

No, HCW Biologics Inc. (HCWB) underperformed the S&P 500 by 126.08 percentage points over the past year. HCWB delivered a total return of -94.75%, compared to the S&P 500's 31.32%. This means a passive S&P 500 index fund outperformed HCWB by 126.08pp during this period.

Q5What is HCWB's worst drawdown?

HCW Biologics Inc. (HCWB) experienced a maximum drawdown of -97.33% over the past year, declining from its peak on 2025-05-13 to its trough on 2026-04-02. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is HCWB's long-term total return over 10, 20, or 30 years?

Here are HCW Biologics Inc. (HCWB)'s long-term returns with dividends reinvested. Over 10 years, the total return is -99.9% (-48.2% CAGR) — $10,000 would have grown to $14. Over 20 years: -99.9% total return (-28.0% CAGR) — $10,000 → $14. Over 30 years: -99.9% total return (-19.7% CAGR) — $10,000 → $14. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was HCWB's best and worst year?

HCW Biologics Inc.'s best calendar year was 2022 with a total return of -19.2%. Its worst year was 2025 with a total return of -94.6%. This range shows the volatility investors should expect — the difference between the best and worst year is 75.4 percentage points.